[S02DA03, antipyrine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Nitroprusside.]
[J01GA01, streptomycin, Nitroprusside may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Nitroprusside may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Nitroprusside may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Sulfamethoxazole.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Sulfapyridine.]
[M01AB02, sulindac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Sulindac.]
[M01AX04, apazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Azapropazone.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Nitroprusside.]
[B01AE07, dabigatran etexilate, Nitroprusside may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Nitroprusside may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Tetracaine.]
[S03AA02, tetracycline, Nitroprusside may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Nitroprusside.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Nitroprusside may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Nitroprusside may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Nitroprusside.]
[N05AB08, thioproperazine, Thioproperazine may decrease the antihypertensive activities of Nitroprusside.]
[N05AC02, thioridazine, Thioridazine may decrease the antihypertensive activities of Nitroprusside.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Nitroprusside.]
[N05AL03, tiapride, Nitroprusside may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S01ED01, timolol, Nitroprusside may increase the hypotensive activities of Timolol.]
[P01AB02, tinidazole, Nitroprusside may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Nitroprusside may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Nitroprusside may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may decrease the antihypertensive activities of Nitroprusside.]
[V04CA01, tolbutamide, Nitroprusside may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Tolmetin.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Nitroprusside.]
[N06AX05, trazodone, Trazodone may decrease the antihypertensive activities of Nitroprusside.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tretinoin.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Nitroprusside may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Trichlormethiazide.]
[A16AX12, trientine, Triethylenetetramine can cause a decrease in the absorption of Nitroprusside resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AB06, trifluoperazine, Trifluoperazine may decrease the antihypertensive activities of Nitroprusside.]
[S01AD02, trifluridine, Nitroprusside may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[A03AA05, trimebutine, Trimebutine may increase the hypotensive activities of Nitroprusside.]
[S01ED04, metipranolol, Nitroprusside may increase the hypotensive activities of Metipranolol.]
[N03AC02, trimethadione, Trimethadione may increase the hypotensive activities of Nitroprusside.]
[C02BA01, trimethaphan, Nitroprusside may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, Nitroprusside may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[N06AA06, trimipramine, Trimipramine may decrease the antihypertensive activities of Nitroprusside.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Nitroprusside.]
[C09CA09, azilsartan medoxomil, Nitroprusside may increase the hypotensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, Nitroprusside may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Nitroprusside may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Nitroprusside may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[S01AA28, vancomycin, Nitroprusside may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Nitroprusside may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Nitroprusside may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Nitroprusside.]
[C08DA01, verapamil, Verapamil may increase the hypotensive activities of Nitroprusside.]
[N06AX09, viloxazine, Nitroprusside may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[C04AX07, vincamine, Nitroprusside may increase the hypotensive activities of Vincamine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[B01AA03, warfarin, Nitroprusside may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Nitroprusside.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, Zuclopenthixol may decrease the antihypertensive activities of Nitroprusside.]
[M05BA03, pamidronic acid, Nitroprusside can cause a decrease in the absorption of Pamidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M05BA05, tiludronic acid, Nitroprusside can cause a decrease in the absorption of Tiludronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B06AC02, icatibant, Nitroprusside may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Nitroprusside may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, Nitroprusside can cause a decrease in the absorption of Ibandronate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01MA13, trovafloxacin, Nitroprusside can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Nitroprusside.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, The serum concentration of Deferiprone can be decreased when it is combined with Nitroprusside.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Nitroprusside.]
[L01EJ01, ruxolitinib, Nitroprusside may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Nitroprusside may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Nitroprusside may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Nitroprusside may increase the hypotensive activities of Atenolol.]
[L01FA01, rituximab, Nitroprusside may increase the hypotensive activities of Rituximab.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Nitroprusside.]
[M01CB03, auranofin, Nitroprusside may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Nitroprusside may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Nitroprusside may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Nitroprusside may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Nitroprusside may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Nitroprusside may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G04BE10, avanafil, Nitroprusside may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Nitroprusside.]
[A08AA11, lorcaserin, Nitroprusside may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Nitroprusside.]
[L02BB04, enzalutamide, Nitroprusside may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Nitroprusside.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Nitroprusside.]
[D02BA02, octinoxate, Nitroprusside may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Nitroprusside.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Nitroprusside.]
[C08CA13, lercanidipine, Lercanidipine may increase the hypotensive activities of Nitroprusside.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Nitroprusside.]
[V09IX04, fluorodeoxyglucose F18, Nitroprusside may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Nitroprusside.]
[G04BE03, sildenafil, Sildenafil may increase the antihypertensive activities of Nitroprusside.]
[V08CA11, gadofosveset, Nitroprusside may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Nitroprusside may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, Bencyclane may increase the hypotensive activities of Nitroprusside.]
[A10BH04, alogliptin, Nitroprusside may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Nitroprusside may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, Nitroprusside may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, Nitroprusside can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01AE07, moxifloxacin, Nitroprusside can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Benzocaine.]
[L03AA12, ancestim, Nitroprusside may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Celecoxib.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Nitroprusside.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[R02AX03, benzydamine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Benzydamine.]
[L01EE01, trametinib, Nitroprusside may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Nitroprusside may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Nitroprusside may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Bepridil may increase the hypotensive activities of Nitroprusside.]
[C02KX05, riociguat, Nitroprusside may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Nitroprusside may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Nitroprusside may increase the hypotensive activities of Macitentan.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Nitroprusside.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J05AP08, sofosbuvir, Nitroprusside may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Nitroprusside.]
[C07AB04, acebutolol, Nitroprusside may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, Nitroprusside may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Nitroprusside may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Nitroprusside may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Nitroprusside.]
[V03AB34, fomepizole, Nitroprusside may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Nitroprusside.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Empagliflozin.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Nitroprusside.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S01EE02, unoprostone, Nitroprusside may increase the hypotensive activities of Unoprostone.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AA04, acepromazine, Acepromazine may decrease the antihypertensive activities of Nitroprusside.]
[S03AA06, gentamicin, Nitroprusside may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Nitroprusside may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Nitroprusside.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Nitroprusside.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AX16, brexpiprazole, Brexpiprazole may decrease the antihypertensive activities of Nitroprusside.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Nitroprusside.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Nitroprusside.]
[M02AA25, aceclofenac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Aceclofenac.]
[M01AB11, acemetacin, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Nitroprusside may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Nitroprusside.]
[L01XG03, ixazomib, Nitroprusside may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Nitroprusside may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Nitroprusside.]
[M04AB05, lesinurad, Nitroprusside may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Alminoprofen.]
[N03AX23, brivaracetam, Nitroprusside may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Nitroprusside may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, Bromocriptine may decrease the antihypertensive activities of Nitroprusside.]
[A02AD05, aluminum magnesium silicate, Nitroprusside may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Nitroprusside.]
[C08CA01, amlodipine, Amlodipine may increase the hypotensive activities of Nitroprusside.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Nitroprusside.]
[C07AA19, bupranolol, Nitroprusside may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Nitroprusside.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Arsenic trioxide.]
[M02AA03, clofezone, Nitroprusside may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA09, sparfloxacin, Nitroprusside can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A07EC04, balsalazide, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Balsalazide.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Nitroprusside.]
[A06AH05, naldemedine, Nitroprusside may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Nitroprusside may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C09AA07, benazepril, Nitroprusside may increase the hypotensive activities of Benazepril.]
[P01CA02, benznidazole, Nitroprusside may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Nitroprusside.]
[J05AF06, abacavir, Nitroprusside may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Nitroprusside may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[A12AA01, calcium phosphate, Nitroprusside can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Nitroprusside.]
[J01MA23, delafloxacin, Nitroprusside can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01BC06, capecitabine, Nitroprusside may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, Nitroprusside may increase the hypotensive activities of Bisoprolol.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Nitroprusside.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Nitroprusside may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Nitroprusside.]
[M01AB07, bumadizone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Bumadizone.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Nitroprusside.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Nitroprusside may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, Nitroprusside may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, Nitroprusside may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Nitroprusside may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, Carvedilol may increase the hypotensive activities of Nitroprusside.]
[B02BX09, fostamatinib, Fostamatinib may increase the antihypertensive activities of Nitroprusside.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Nitroprusside.]
[L04AA37, baricitinib, Nitroprusside may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01GB14, plazomicin, Nitroprusside may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Nitroprusside may increase the hypotensive activities of Celiprolol.]
[A16AX14, migalastat, Nitroprusside may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Nitroprusside may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, Nitroprusside may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Nitroprusside may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Lornoxicam.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[A06AX05, prucalopride, Nitroprusside may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, Nitroprusside may increase the hypotensive activities of Cilazapril.]
[B01AC23, cilostazol, Nitroprusside may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Nitroprusside.]
[S01ED05, carteolol, Nitroprusside may increase the hypotensive activities of Carteolol.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Nitroprusside.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Nitroprusside.]
[N05BA09, clobazam, Nitroprusside may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[C09CA06, candesartan, Nitroprusside may increase the hypotensive activities of Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N07XX11, pitolisant, Nitroprusside may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Nitroprusside.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[M09AX08, golodirsen, Nitroprusside may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Nitroprusside may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[S01AE06, gatifloxacin, Nitroprusside can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Nitroprusside.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Nitroprusside.]
[R02AA03, dichlorobenzyl alcohol, Nitroprusside may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Nitroprusside may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Nitroprusside.]
[M01AH02, rofecoxib, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Rofecoxib.]
[C08CA16, clevidipine, Clevidipine may increase the hypotensive activities of Nitroprusside.]
[C01BD07, dronedarone, Dronedarone may decrease the antihypertensive activities of Nitroprusside.]
[C02AA06, methoserpidine, Nitroprusside may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Nitroprusside.]
[M01AC04, droxicam, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Droxicam.]
[V08CA05, mangafodipir, Nitroprusside may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Nitroprusside.]
[M02AA27, dexketoprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Dexketoprofen.]
[C08CA17, levamlodipine, Levamlodipine may increase the hypotensive activities of Nitroprusside.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Chloroquine.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the antihypertensive activities of Nitroprusside.]
[A10BB02, chlorpropamide, Nitroprusside may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Nitroprusside may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ethenzamide.]
[N02BA03, choline salicylate, Nitroprusside may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, Vinpocetine may increase the hypotensive activities of Nitroprusside.]
[M01AB08, etodolac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Etodolac.]
[M02AA06, etofenamate, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Etofenamate.]
[M01AX25, chondroitin sulfates, Nitroprusside may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Nitroprusside.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Vericiguat.]
[M01AE05, fenbufen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Fenbufen.]
[C01CA19, fenoldopam, Nitroprusside may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Nitroprusside.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Nitroprusside.]
[J01DD15, cefdinir, Nitroprusside may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[J01MB07, flumequine, Nitroprusside can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S02BA08, fluocinolone acetonide, Nitroprusside may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Nitroprusside may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Nitroprusside.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Nitroprusside.]
[H04AA02, dasiglucagon, Nitroprusside may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, Nitroprusside may decrease the excretion rate of Cimetidine which could result in a higher serum level.]
[V08CA04, gadoteridol, Nitroprusside may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the hypotensive activities of Nitroprusside.]
[J01MB06, cinoxacin, Nitroprusside can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S03AA07, ciprofloxacin, Nitroprusside can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01XA01, cisplatin, Nitroprusside may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Nitroprusside may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Nitroprusside may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Nitroprusside may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Mefenamic acid.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Nitroprusside.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Nitroprusside.]
[N03AE01, clonazepam, Nitroprusside may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Nitroprusside.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the antihypertensive activities of Nitroprusside.]
[J01GB12, arbekacin, Nitroprusside may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[C02KB01, metyrosine, Nitroprusside may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Proquazone.]
[M04AC01, colchicine, Nitroprusside may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Nitroprusside may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Nitroprusside.]
[A04AA03, tropisetron, Nitroprusside may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Nitroprusside.]
[A10BX03, nateglinide, Nitroprusside may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Imidazole salicylate.]
[B01AC10, indobufen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Indobufen.]
[J05AB14, valganciclovir, Nitroprusside may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Nitroprusside may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Nitroprusside may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Nitroprusside may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Nitroprusside may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Nitroprusside may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Valdecoxib.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Isometheptene.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Nitroprusside.]
[M01AH04, parecoxib, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Parecoxib.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05BA10, ketazolam, Nitroprusside may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Kebuzone.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Nitroprusside.]
[S01EE03, bimatoprost, Nitroprusside may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Lacidipine may increase the hypotensive activities of Nitroprusside.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Nitroprusside.]
[N03AX09, lamotrigine, Nitroprusside may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Nitroprusside.]
[S01AE04, lomefloxacin, Nitroprusside can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB09, lonazolac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Lonazolac.]
[M02AA31, loxoprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Loxoprofen.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C09AA03, lisinopril, Nitroprusside may increase the hypotensive activities of Lisinopril.]
[A06AD01, magnesium carbonate, Nitroprusside may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Manidipine may increase the hypotensive activities of Nitroprusside.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Nitroprusside.]
[J01DH02, meropenem, Nitroprusside may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, Cyclandelate may increase the hypotensive activities of Nitroprusside.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Nitroprusside.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Nitroprusside may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Cyclophosphamide.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Nitroprusside.]
[S01XA18, cyclosporine, Cyclosporine may decrease the antihypertensive activities of Nitroprusside.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Nitroprusside.]
[C09AA13, moexipril, Nitroprusside may increase the hypotensive activities of Moexipril.]
[M02AA02, mofebutazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Mofebutazone.]
[M01AX22, morniflumate, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Morniflumate.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Nitroprusside.]
[G04BE09, vardenafil, Vardenafil may increase the antihypertensive activities of Nitroprusside.]
[M01AH05, etoricoxib, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Etoricoxib.]
[L01AX04, dacarbazine, Nitroprusside may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Nitroprusside.]
[C02CC04, debrisoquin, Nitroprusside may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Nabilone.]
[M01AX01, nabumetone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Nabumetone.]
[N07BB05, nalmefene, Nitroprusside may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, Nitroprusside may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Nitroprusside may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the antihypertensive activities of Nitroprusside.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Nitroprusside.]
[L02BB02, nilutamide, Nitroprusside may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Nitroprusside.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Nitroprusside.]
[B01AX05, fondaparinux, Nitroprusside may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Nitroprusside.]
[A07EC03, olsalazine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Olsalazine.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Nitroprusside.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Nitroprusside.]
[V04CH02, indigo carmine, Nitroprusside may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C09XA02, aliskiren, Nitroprusside may increase the hypotensive activities of Aliskiren.]
[M01AE12, oxaprozin, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Oxaprozin.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Nitroprusside.]
[P03AC04, permethrin, Nitroprusside may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Nitroprusside may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Nitroprusside.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Nitroprusside.]
[R05DA08, pholcodine, Nitroprusside may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, Nitroprusside can cause a decrease in the absorption of Clodronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[A03AA07, dicyclomine, Nitroprusside may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Nitroprusside may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Nitroprusside may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, Pinaverium may increase the hypotensive activities of Nitroprusside.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Pipamperone.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Nitroprusside.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Nitroprusside.]
[C08CA03, isradipine, Isradipine may increase the hypotensive activities of Nitroprusside.]
[D07XC04, diflucortolone, Nitroprusside may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Diflunisal.]
[C01AA05, digoxin, Nitroprusside may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Nitroprusside may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may decrease the antihypertensive activities of Nitroprusside.]
[N02CA01, dihydroergotamine, Dihydroergotamine may decrease the antihypertensive activities of Nitroprusside.]
[N02AA03, hydromorphone, Nitroprusside may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Nitroprusside may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Nitroprusside.]
[H03BC01, potassium perchlorate, Nitroprusside may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Nitroprusside may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the hypotensive activities of Nitroprusside.]
[V03AB09, dimercaprol, Dimercaprol may increase the nephrotoxic activities of Nitroprusside.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Nitroprusside.]
[M02AX03, dimethyl sulfoxide, Nitroprusside may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Propyphenazone.]
[M01AB14, proglumetacin, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Proglumetacin.]
[C09AA06, quinapril, Nitroprusside may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Nitroprusside.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Nitroprusside.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Nitroprusside.]
[C09AA05, ramipril, Ramipril may increase the hypotensive activities of Nitroprusside.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Nitroprusside.]
[S01AX06, resorcinol, Nitroprusside may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AX08, risperidone, Nitroprusside may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Nitroprusside may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Nitroprusside.]
[J01MB01, rosoxacin, Nitroprusside can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Nitroprusside may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ketorolac.]
[C02KX02, ambrisentan, Nitroprusside may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N02BA06, salsalate, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Nitroprusside.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Nitroprusside.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Nitroprusside.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Nitroprusside.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Nitroprusside.]
[N06AA12, doxepin, Doxepin may decrease the antihypertensive activities of Nitroprusside.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Nitroprusside.]
[N05AD08, droperidol, Droperidol may decrease the antihypertensive activities of Nitroprusside.]
[A08AA10, sibutramine, Nitroprusside may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[V03AG05, sodium phosphate, Nitroprusside can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CA02, sodium sulfate, Nitroprusside may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Nitroprusside may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Nitroprusside may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Nitroprusside.]
[V04CX07, edrophonium, Nitroprusside may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Nitroprusside may increase the hypotensive activities of Talinolol.]
[J01MA05, temafloxacin, Nitroprusside can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01AX03, temozolomide, Nitroprusside may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, Nitroprusside may increase the hypotensive activities of Terazosin.]
[G04BD05, terodiline, Terodiline may increase the hypotensive activities of Nitroprusside.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Nitroprusside.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Nitroprusside.]
[C09AA02, enalapril, Nitroprusside may increase the hypotensive activities of Enalapril.]
[M01AG02, tolfenamic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Nitroprusside.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Nitroprusside.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Nitroprusside.]
[C09AA10, trandolapril, Nitroprusside may increase the hypotensive activities of Trandolapril.]
[N05CC01, chloral hydrate, Nitroprusside may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Nitroprusside.]
[C02CA06, urapidil, Urapidil may decrease the antihypertensive activities of Nitroprusside.]
[J01MA04, enoxacin, Nitroprusside can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Nitroprusside.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Nitroprusside.]
[S01GA03, xylometazoline, Xylometazoline may increase the hypotensive activities of Nitroprusside.]
[C08CA12, mepirodipine, Barnidipine may increase the hypotensive activities of Nitroprusside.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Nitroprusside.]
[C09AA15, zofenopril, Nitroprusside may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the hypotensive activities of Nitroprusside.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Zopiclone.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Nitroprusside.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Nitroprusside.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Nitroprusside.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Nitroprusside.]
[N02CA02, ergotamine, Ergotamine may decrease the antihypertensive activities of Nitroprusside.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Nitroprusside.]
[L03AX05, pidotimod, Nitroprusside may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Nitroprusside may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G03CA03, estradiol, Nitroprusside may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J04AK02, ethambutol, Nitroprusside may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Nitroprusside.]
[V03AF05, amifostine, Nitroprusside may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N03AD01, ethosuximide, Ethosuximide may increase the hypotensive activities of Nitroprusside.]
[M01AC06, meloxicam, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Meloxicam.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Nitroprusside.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Nitroprusside.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01MA08, fleroxacin, Nitroprusside can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[P01AX07, trimetrexate, Nitroprusside may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Nitroprusside may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Nitroprusside may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Nitroprusside may decrease the excretion rate of Dextran which could result in a higher serum level.]
[M05BA01, etidronic acid, Nitroprusside can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V03AF02, dexrazoxane, Nitroprusside may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Nitroprusside may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[C08CA02, felodipine, Felodipine may increase the hypotensive activities of Nitroprusside.]
[C08EA01, fendiline, Fendiline may increase the hypotensive activities of Nitroprusside.]
[M01AE04, fenoprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Nitroprusside.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Nitroprusside.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Nitroprusside.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Clofarabine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G04BD02, flavoxate, Nitroprusside may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Floctafenine.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J02AX01, flucytosine, Nitroprusside may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Nitroprusside may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Flunarizine may increase the hypotensive activities of Nitroprusside.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Nitroprusside.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Nitroprusside.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AF01, flupenthixol, Flupentixol may decrease the antihypertensive activities of Nitroprusside.]
[N05CD01, flurazepam, Nitroprusside may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Flurbiprofen.]
[N05AG01, fluspirilene, Fluspirilene may increase the hypotensive activities of Nitroprusside.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Flutamide.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[S02AA17, fosfomycin, Nitroprusside may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[L01BC03, tegafur, Nitroprusside may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Nitroprusside.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Nitroprusside.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA04, alendronic acid, Nitroprusside can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CF04, eszopiclone, Nitroprusside may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[C08DA02, gallopamil, Gallopamil may increase the hypotensive activities of Nitroprusside.]
[S01AD09, ganciclovir, Nitroprusside may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Nitroprusside.]
[C10AB04, gemfibrozil, Nitroprusside may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Nitroprusside may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Cabergoline may decrease the antihypertensive activities of Nitroprusside.]
[N03AD03, methsuximide, Methsuximide may increase the hypotensive activities of Nitroprusside.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Nitroprusside.]
[A10BB07, glipizide, Nitroprusside may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Nitroprusside.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitroglycerin.]
[C02CA04, doxazosin, Nitroprusside may increase the hypotensive activities of Doxazosin.]
[L01EX02, sorafenib, Nitroprusside may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Nitroprusside.]
[M01CB04, aurothioglucose, Nitroprusside may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Nitroprusside may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Nitroprusside may increase the hypotensive activities of Fosinopril.]
[S01EX01, guanethidine, Nitroprusside may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AD01, haloperidol, Nitroprusside may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Nitroprusside.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Nitroprusside.]
[N06BX13, idebenone, Nitroprusside may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Nitroprusside may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, Nitroprusside may increase the hypotensive activities of Losartan.]
[G03DC01, allylestrenol, Nitroprusside may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Mesalazine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Nitroprusside.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Nitroprusside.]
[C08CA10, nilvadipine, Nilvadipine may increase the hypotensive activities of Nitroprusside.]
[M02AA26, nimesulide, Nimesulide may increase the hypotensive activities of Nitroprusside.]
[C09AA04, perindopril, Nitroprusside may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Nitroprusside may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, Nitroprusside may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the antihypertensive activities of Nitroprusside.]
[B05AA07, hetastarch, Nitroprusside may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Nitroprusside.]
[M05BA07, risedronic acid, Nitroprusside can cause a decrease in the absorption of Risedronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R02AX02, ibuprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ibuprofen.]
[B05XA08, sodium acetate, Nitroprusside may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Ifosfamide.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Nitroprusside.]
[N06AA02, imipramine, Imipramine may decrease the antihypertensive activities of Nitroprusside.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Paclitaxel.]
[R01AD07, tixocortol, Nitroprusside may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tizanidine.]
[L01CE01, topotecan, Nitroprusside may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Nitroprusside.]
[S01BC01, indomethacin, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, Indoramin may decrease the antihypertensive activities of Nitroprusside.]
[A11HA07, inositol, Nitroprusside may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Nitroprusside may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Nitroprusside may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Articaine.]
[A10BH01, sitagliptin, Nitroprusside may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Nitroprusside may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Nitroprusside may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C07AA01, alprenolol, Nitroprusside may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Nitroprusside may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Nitroprusside.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Nitroprusside.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Nitroprusside.]
[S01EC03, dorzolamide, Nitroprusside may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Nitroprusside.]
[C09AA16, imidapril, Nitroprusside may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Nitroprusside.]
[J04AC01, isoniazid, Nitroprusside may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Nitroprusside may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Nitroprusside.]
[C01DA14, isosorbide mononitrate, Nitroprusside may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Nitroprusside may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Nitroprusside.]
[S01AA24, kanamycin, Nitroprusside may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Nitroprusside may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Nitroprusside may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Nitroprusside may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Olanzapine.]
[M02AA10, ketoprofen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Ketoprofen.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Nitroprusside.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Nitroprusside.]
[D10AX03, azelaic acid, Nitroprusside may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[J01MB02, nalidixic acid, Nitroprusside can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Tiaprofenic acid.]
[C07AG01, labetalol, Nitroprusside may increase the hypotensive activities of Labetalol.]
[N04BB01, amantadine, Nitroprusside may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Nitroprusside may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Nitroprusside may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Nitroprusside is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Nitroprusside.]
[C08EX01, lidoflazine, Lidoflazine may increase the hypotensive activities of Nitroprusside.]
[S01AA21, amikacin, Nitroprusside may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Nitroprusside.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Nitroprusside.]
[A07DA03, loperamide, Loperamide may increase the hypotensive activities of Nitroprusside.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[B05XA11, magnesium chloride, Nitroprusside may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Nitroprusside may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the hypotensive activities of Nitroprusside.]
[L01BA05, pralatrexate, Nitroprusside may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Nitroprusside may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Nitroprusside may increase the hypotensive activities of Mecamylamine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Nitroprusside may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Nitroprusside may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Nitroprusside.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Nitroprusside.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Mepivacaine.]
[G04BX16, tiopronin, Nitroprusside may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the antihypertensive activities of Nitroprusside.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Nitroprusside.]
[A10BA02, metformin, Nitroprusside may decrease the excretion rate of Metformin which could result in a higher serum level.]
[N07BC02, methadone, Nitroprusside may decrease the excretion rate of Methadone which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Nitroprusside.]
[J05AF05, lamivudine, Nitroprusside may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Nitroprusside.]
[H03BB02, methimazole, Nitroprusside may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Nitroprusside may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Nitroprusside.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N02BG08, ziconotide, Ziconotide may increase the hypotensive activities of Nitroprusside.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Methotrimeprazine may decrease the antihypertensive activities of Nitroprusside.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Nitroprusside.]
[D05BA02, methoxsalen, Nitroprusside may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Nitroprusside.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Nitroprusside can cause a decrease in the absorption of Methyldopa resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Nitroprusside.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Nitroprusside.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Nitroprusside.]
[G03EK01, methyltestosterone, Nitroprusside may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, Methysergide may decrease the antihypertensive activities of Nitroprusside.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Nitroprusside.]
[V04CD01, metyrapone, Nitroprusside may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Nitroprusside.]
[N02BB03, aminopyrine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Aminophenazone.]
[N05CD08, midazolam, Nitroprusside may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Nitroprusside.]
[J05AH01, zanamivir, Nitroprusside may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, Valsartan may increase the hypotensive activities of Nitroprusside.]
[D11AX01, minoxidil, Nitroprusside may increase the hypotensive activities of Minoxidil.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Nitroprusside.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroprusside.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Nitroprusside.]
[C01BD01, amiodarone, Amiodarone may increase the hypotensive activities of Nitroprusside.]
[N06AA09, amitriptyline, Amitriptyline may decrease the antihypertensive activities of Nitroprusside.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Nitroprusside.]
[A04AA05, palonosetron, Nitroprusside may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Nitroprusside may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Nitroprusside may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Nitroprusside may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Nitroprusside.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Nitroprusside is combined with Silodosin.]
[N06AA17, amoxapine, Amoxapine may decrease the antihypertensive activities of Nitroprusside.]
[C07AA12, nadolol, Nitroprusside may increase the hypotensive activities of Nadolol.]
[J01CA04, amoxicillin, Nitroprusside may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Nitroprusside.]
[V03AB15, naloxone, Nitroprusside may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Nitroprusside.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Nitroprusside.]
[M02AA12, naproxen, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Naproxen.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Nitroprusside is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Nitroprusside.]
[S03AA01, neomycin, Nitroprusside may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Nitroprusside.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Levosimendan.]
[B01AC17, tirofiban, Nitroprusside may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, Iloperidone may decrease the antihypertensive activities of Nitroprusside.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Amphotericin B.]
[S01AA19, ampicillin, Nitroprusside may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Nitroprusside may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Nitroprusside may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Nitroprusside may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Nitroprusside may increase the hypotensive activities of Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C01CE01, inamrinone, Nitroprusside may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Nitroprusside.]
[C08CA04, nicardipine, Nicardipine may increase the hypotensive activities of Nitroprusside.]
[C04AE02, nicergoline, Nicergoline may decrease the antihypertensive activities of Nitroprusside.]
[C08CA05, nifedipine, Nifedipine may increase the hypotensive activities of Nitroprusside.]
[M02AA17, niflumic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the hypotensive activities of Nitroprusside.]
[C08CA07, nisoldipine, Nisoldipine may increase the hypotensive activities of Nitroprusside.]
[C08CA08, nitrendipine, Nitrendipine may increase the hypotensive activities of Nitroprusside.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitrofurantoin.]
[N05CF03, zaleplon, Nitroprusside may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Pramipexole.]
[J01MB04, pipemidic acid, Nitroprusside can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C01DA05, pentaerythritol tetranitrate, Nitroprusside may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Nitrous oxide.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Nitroprusside.]
[S01AE02, norfloxacin, Nitroprusside can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02KX01, bosentan, Nitroprusside may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may decrease the antihypertensive activities of Nitroprusside.]
[G02CA02, nylidrin, Nylidrin may increase the hypotensive activities of Nitroprusside.]
[S02AA16, ofloxacin, Nitroprusside can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BC01, omeprazole, The absorption of Nitroprusside can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Nitroprusside.]
[N02AA02, opium, Nitroprusside may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Nitroprusside.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tamsulosin.]
[M05BA08, zoledronic acid, Nitroprusside can cause a decrease in the absorption of Zoledronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01CF04, oxacillin, Nitroprusside may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Nitroprusside may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[J01MB05, oxolinic acid, Nitroprusside can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AA02, oxprenolol, Nitroprusside may increase the hypotensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Nitroprusside.]
[S01GA04, oxymetazoline, Oxymetazoline may decrease the antihypertensive activities of Nitroprusside.]
[S01BC02, oxyphenbutazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Oxyphenbutazone.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Nitroprusside.]
[N05AH05, asenapine, Asenapine may decrease the antihypertensive activities of Nitroprusside.]
[J04AB30, capreomycin, Nitroprusside may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Nitroprusside.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01MA03, pefloxacin, Nitroprusside can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BD11, fesoterodine, Nitroprusside may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Nitroprusside may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, Penfluridol may increase the hypotensive activities of Nitroprusside.]
[J01CE09, penicillin G procaine, Nitroprusside may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Nitroprusside.]
[L01XX08, pentostatin, Nitroprusside may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Nitroprusside.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Nitroprusside.]
[C08EX02, perhexiline, Perhexiline may increase the hypotensive activities of Nitroprusside.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Phenazopyridine.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Nitroprusside.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Nitroprusside.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may decrease the antihypertensive activities of Nitroprusside.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Nitroprusside.]
[V03AB36, phentolamine, Phentolamine may decrease the antihypertensive activities of Nitroprusside.]
[M02AA01, phenylbutazone, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Phenylbutazone.]
[S01GA05, phenylephrine, Phenylephrine may decrease the antihypertensive activities of Nitroprusside.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Nitroprusside.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Nitroprusside.]
[S01AE05, levofloxacin, Nitroprusside can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B02BA01, vitamin K1, Nitroprusside may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C08CX01, mibefradil, Mibefradil may increase the hypotensive activities of Nitroprusside.]
[C07AA03, pindolol, Nitroprusside may increase the hypotensive activities of Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N06BX03, piracetam, Nitroprusside may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, Nitroprusside may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[J01MA11, grepafloxacin, Nitroprusside can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CX01, pizotyline, Pizotifen may decrease the antihypertensive activities of Nitroprusside.]
[C09CA04, irbesartan, Nitroprusside may increase the hypotensive activities of Irbesartan.]
[A10BG02, rosiglitazone, Nitroprusside may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[C03AA05, polythiazide, The therapeutic efficacy of Nitroprusside can be increased when used in combination with Polythiazide.]
[A10BH03, saxagliptin, Nitroprusside may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Nitroprusside may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C07AB01, practolol, Nitroprusside may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Nitroprusside.]
[H02AB07, prednisone, Nitroprusside may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[C01DX02, prenylamine, Prenylamine may increase the hypotensive activities of Nitroprusside.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Nitroprusside.]
[M04AB01, probenecid, Nitroprusside may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Nitroprusside may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Nitroprusside.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Nitroprusside.]
[C10AB05, fenofibrate, Nitroprusside may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, Promazine may decrease the antihypertensive activities of Nitroprusside.]
[R06AD02, promethazine, Nitroprusside may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Nitroprusside.]
[A03AB05, propantheline, Nitroprusside may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N05AC01, periciazine, Periciazine may decrease the antihypertensive activities of Nitroprusside.]
[N05CM06, propiomazine, Propiomazine may decrease the antihypertensive activities of Nitroprusside.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Nitroprusside.]
[C07AA05, propranolol, Nitroprusside may increase the hypotensive activities of Propranolol.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Nitroprusside.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Nitroprusside.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Nitroprusside.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Nitroprusside.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Nitroprusside.]
[N07XX07, dalfampridine, Nitroprusside may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Nitroprusside may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Nitroprusside may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Nitroprusside may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Quinine.]
[A02BA02, ranitidine, Nitroprusside may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Nitroprusside.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Nitroprusside.]
[J05AP01, ribavirin, Nitroprusside may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Nitroprusside.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Nitroprusside.]
[N02BA05, salicylamide, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Salicylamide.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Nitroprusside.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Nitroprusside.]
[L01FA03, obinutuzumab, Nitroprusside may increase the hypotensive activities of Obinutuzumab.]
[J01GB08, sisomicin, Nitroprusside may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Nitroprusside may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Nitroprusside may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Sotalol.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
